SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-034670
Filing Date
2017-06-28
Accepted
2017-06-28 17:09:28
Documents
5
Period of Report
2017-06-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v469811_8k.htm 8-K 22654
2 EXHIBIT 10.1 v469811_ex10-1.htm EX-10.1 103184
3 EXHIBIT 10.2 v469811_ex10-2.htm EX-10.2 30578
4 EXHIBIT 10.3 v469811_ex10-3.htm EX-10.3 33375
5 EXHIBIT 10.4 v469811_ex10-4.htm EX-10.4 35621
  Complete submission text file 0001144204-17-034670.txt   226585
Mailing Address 12325 EMMET STREET OMAHA NE 68164
Business Address 12325 EMMET ST OMAHA NE 68164 4027385480
TRANSGENOMIC INC (Filer) CIK: 0001043961 (see all company filings)

IRS No.: 911789357 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36439 | Film No.: 17936063
SIC: 3826 Laboratory Analytical Instruments
Office of Life Sciences